Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment

This article was originally published here

The in-human study follows positive pre-clinical results for the treatment candidate, as well as successive approval of the investigational new drug application by the Korean Ministry of Food

The post Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply